Simulect 20 mg powder and solvent for solution for injection or infusion

Licence status
Authorised: 09/10/1998
Active substances
Basiliximab
Dosage Form
Powder and solvent for solution for injection/infusion
Licence number
EU/1/98/084/001
Licence holder
Novartis Europharm Limited

Product documents

Licence information

ATC code
L04AC Interleukin inhibitors, L04AC02 basiliximab
Legal supply status
Product subject to Restricted Prescription (C)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
09/10/1998